Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 17
Open Access
- 17 July 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 295 (29), 9948-9958
- https://doi.org/10.1074/jbc.RA119.010981
Abstract
No abstract availableFunding Information
- HHS | NIH | National Cancer Institute (U54-CA196519-04)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (R01NS104489-02)
- HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12-HD000850-35)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (5T32DK007519-34)
This publication has 51 references indexed in Scilit:
- RAS Proteins and Their Regulators in Human DiseaseCell, 2017
- Dragging Ras Back in the RingCancer Cell, 2014
- Optimizing biologically targeted clinical trials for neurofibromatosisExpert Opinion on Investigational Drugs, 2013
- Pathogenesis of Plexiform Neurofibroma: Tumor-Stromal/Hematopoietic Interactions in Tumor ProgressionAnnual review of pathology, 2012
- Neurofibromin GTPase-activating Protein-related Domains Restore Normal Growth in Nf1−/− CellsOnline Journal of Public Health Informatics, 2001
- Epidermal growth factor receptor expression in neurofibromatosis type 1–related tumors and NF1 animal modelsJCI Insight, 2000
- Nf1 and Gmcsf Interact in Myeloid LeukemogenesisMolecular Cell, 2000
- The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21Cell, 1990
- Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 PatientsScience, 1990
- Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locusCell, 1990